Patents/Assignees

FORMA Therapeutics, Inc.

16 patents in portfolio

US12454532utility2025
Inhibiting Cyclic Amp-responsive Element-binding Protein (CREB) Binding Protein (CBP)
0 cites
US12378242utility2025
Inhibiting CREB Binding Protein (CBP)
0 cites
US12351577utility2025
Inhibiting Cyclic Amp-responsive Element-binding Protein (CREB)
0 cites
US12275715utility2025
Pyridin-2(1h)-one Quinolinone Derivatives as Mutant-isocitrate Dehydrogenase Inhibitors
0 cites
US12053463utility2024
Solid Forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
0 cites
US12049466utility2024
Fused Bicyclic Compounds Useful as Ubiquitin-specific Peptidase 30 Inhibitors
0 cites
US12043623utility2024
Purinones as Ubiquitin-specific Protease 1 Inhibitors
0 cites
US11963956utility2024
Inhibiting Mutant Isocitrate Dehydrogenase 1 (midh-1)
0 cites
US11814386utility2023
Fused Pyrrolines Which Act as Ubiquitin-specific Protease 30 (USP30) Inhibitors
0 cites
US11801243utility2023
Bromodomain Inhibitors for Androgen Receptor-driven Cancers
0 cites
US11795168utility2023
Inhibiting Cyclic Amp-responsive Element-binding Protein (CREB) Binding Protein (CBP)
0 cites
US11787803utility2023
Tetrahydro-imidazo Quinoline Compositions as CBP/P300 Inhibitors
0 cites
US11723905utility2023
Solid Forms of ((s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile
0 cites
US11649242utility2023
Pyrrolopyrrole Compositions as Pyruvate Kinase (PKR) Activators
0 cites
US11576906utility2023
Inhibiting Mutant IDH-1
0 cites
US11566013utility2023
Inhibiting Mutant Isocitrate Dehydrogenase 1 (midh1)
0 cites